BioAge Labs BIOA
NASDAQ BIOA
$9.17 -0.23 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Non-Current Assets (2023 - 2026)

BioAge Labs' (BIOA) quarterly Non-Current Assets came in at $66.6 million in Q2 2026, up 225.74% year-over-year from $20.5 million in Q2 2025, and up 1049.76% quarter-over-quarter from $5.8 million in Q1 2026.

Analysis

BioAge Labs (BIOA) Non-Current Assets (2023 - 2026) Analysis & Trends

BioAge Labs has disclosed Non-Current Assets across 4 years of filings, most recently posting $66.6 million for Q2 2026.

  • In Q2 2026, Non-Current Assets rose 225.74% year-over-year to $66.6 million; the TTM figure through Jun 2026 stood at $94.8 million (up 128.23% YoY), while the FY2025 annual figure was $8.1 million, up 615.83% from the prior year.
  • Non-Current Assets came in at $66.6 million for Q2 2026 at BioAge Labs, up from $5.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $66.6 million in Q2 2026 to a low of $618000.0 in Q4 2023.
  • Average Non-Current Assets over 4 years is $15.2 million, with a median of $8.1 million recorded in 2025.
  • Year-over-year, Non-Current Assets jumped 1460.39% in 2025 and plunged 69.55% in 2026.
  • Over 4 years, Non-Current Assets stood at $618000.0 in 2023, then soared by 83.01% to $1.1 million in 2024, then soared by 615.83% to $8.1 million in 2025, then surged by 722.84% to $66.6 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $66.6 million in Q2 2026, $5.8 million in Q1 2026, and $8.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.96 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 564.41 Mn
10 BioAge Labs 409.83 Mn 409.83 Mn -14.23 Mn 66.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.62 Mn
Mar 31, 2026 5.79 Mn
Dec 31, 2025 8.10 Mn
Sep 30, 2025 14.26 Mn
Jun 30, 2025 20.45 Mn
Mar 31, 2025 19.03 Mn
Dec 31, 2024 1.13 Mn
Sep 30, 2024 914,000.00
Dec 31, 2023 618,000.00